Designing Small-Molecule Allosteric Inhibitors of CYP2C19 to Prevent Clopidogrel Resistance in Patients With Specific Genetic Polymorphisms. Link Medical Journal, [S. l.], v. 3, n. 2, p. e76, 2025. DOI: 10.61919/gsj6hy59. Disponível em: https://linkmjhcr.com/index.php/lmj/article/view/76. Acesso em: 19 feb. 2026.